Can Pan-Colonic Chromoendoscopy (PCC) Improve Adenoma Detection Rate in FIT-Positive-Patients: A Randomized Study (PCC)
Primary Purpose
Colon Adenoma
Status
Unknown status
Phase
Not Applicable
Locations
Singapore
Study Type
Interventional
Intervention
Chromoendoscopy
High definition white light colonoscopy
Sponsored by
About this trial
This is an interventional diagnostic trial for Colon Adenoma focused on measuring FIT- positive, Chromoendoscopy, white light endoscopy, adenoma detection rate, advanced adenoma rate, serrated adenoma rate
Eligibility Criteria
Inclusion Criteria:
- Age older than 50 years
- Positive stool FIT test or FOBT test
Exclusion Criteria:
- Known inflammatory bowel disease
- Known polyposis syndromes
- Previous history of colon cancer and surgical resection
- Overt gastrointestinal bleeding
- Stool FIT or FOBT test performed during hospitalization
- Inadequate bowel preparation (Boston Bowel Preparation score <6 or <2 for each colonic segment)
- Poor patient tolerance to the procedure
- Pregnancy
- Concurrent intake of anticoagulants and thienopyridines (e.g., Clopidogrel), where these drugs cannot be suspended for the adequate duration before colonoscopy
- Patient with known history of hypersensitivity to Indigo carmine dye
Sites / Locations
- Singapore General Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Dye based Chromoendoscopy
High Definition White Light Endoscopy
Arm Description
The patients enrolled in this group will undergo pan-colonic chromoendoscopy evaluation.
The patients enrolled in this group will undergo high definition white light endoscopy based evaluation
Outcomes
Primary Outcome Measures
To evaluate the adenoma detection rate between pan-colonic chromoendoscopy and white light colonoscopy
Secondary Outcome Measures
Advanced adenoma detection rate white light colonoscopy
Flat lesion detection rate
Serrated adenoma detection rate
Withdrawal time comparison
Full Information
NCT ID
NCT04512612
First Posted
August 10, 2020
Last Updated
August 12, 2020
Sponsor
Singapore General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04512612
Brief Title
Can Pan-Colonic Chromoendoscopy (PCC) Improve Adenoma Detection Rate in FIT-Positive-Patients: A Randomized Study
Acronym
PCC
Official Title
Can Pan-Colonic Chromoendoscopy (PCC) Improve Adenoma Detection Rate in FIT-Positive-Patients: A Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
August 1, 2022 (Anticipated)
Study Completion Date
August 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Singapore General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Colonoscopy is the technique of choice for evaluation of patients with positive fecal occult blood (FIT). Identification of polyps and their removal has been shown to decrease colorectal cancer incidence rates and mortality. Many endoscopic imaging technologies and devices have been developed to increase adenoma detection (ADR) during screening colonoscopies. They vary in the way they work, and some of the technologies are costly and not widely available. Studies has shown the simple to use pan-colonic chromoendoscopy can improve ADR compared to standard colonoscopy. However, there is little evidence on the utility of pan-colonic chromoendoscopy in asymptomatic individuals undergoing colonoscopy after a positive FIT test. In this randomized study, the investigators aim to compare the utility of chromoendoscopy and high-definition white-light endoscopy in asymptomatic individuals undergoing colonoscopy after a positive FIT test
Detailed Description
Eligible subjects with positive screening FIT test referred to the Department of Gastroenterology, Singapore General Hospital will be approached and recruited. The included patients will be randomised to either a) Group A- Chromoendoscopy or b) Group B- high definition white light based evaluation.
Hypothesis:
The investigators hypothesize that application of non-absorbable dye during colonoscopy would enhance the mucosal contrast, delineate the border and surface patterns by accumulating in the innominate grooves and, thereby, enhance the detection of adenoma during colonoscopy
Procedure:
Pan-colonic chromoendoscopy and high-definition white light endoscopy will be performed by five experienced endoscopist, and hospital sedation guidelines will be followed. The colonoscopy will be performed using Olympus (CF-HQ190) or Fujifilm (EC-590) colonoscopies. Indigo carmine dye will be used for pan-colonic chromoendoscopy. Two ampules of Indigo carmine (0.8%, 5ml/ampule) will be dissolved in 250 ml of water and sprayed through the waterjet channel by using the auxiliary foot pump upon reaching the caecum.
The colonoscopy insertion will be performed using high-definition white light, and the scope will be advanced till the caecum. The quality of the bowel preparation will be rated according to the validated Boston bowel preparation score. Participants with inadequate bowel preparation score (Score <6) will be excluded from the study. The fecal residue will be washed, suctioned and cleared during insertion to improve visibility. No special care will be taken to look for lesions during the insertion. Assessment for colonic lesions will only be performed during withdrawal of the endoscope. The minimum withdrawal time was set at 7 minutes. Randomization: Once the caecum is intubated and if the bowel preparation is adequate, the participants will be randomized to pan-colonic chromoendoscopy based withdrawal or high-definition while light based withdrawal. In the pan-colonic chromoendoscopy group, the indigo carmine was sprayed by pressing the auxiliary foot pump, and dye was delivered systematically to coat the entire colonic mucosa. In both, the groups, the lesion size, number, location, morphology will be documented during withdrawal. The investigators characterized the morphology of the lesion according to the established Paris classification. The investigators characterized the lesion as flat neoplasm if the lesion project <2.5mm or polypoid lesion if lesion project >2.5mm into the lumen. The investigators measured the size of the lesions using an open biopsy forceps when needed.
In both the groups, the identified polyps will be removed using the standard techniques, and the tissue will be placed in separate formalin bottles and sent for histology assessment. The histology of the polyps was assessed by dedicated pathologist trained in gastrointestinal pathology. Both the endoscopists and the pathologist will not be blinded to the study technique. The investigators defined advanced adenoma as any adenoma >10 mm in size or with >25% villous histology or high-grade dysplasia. The investigators classified hyperplastic polyps and sessile serrated polyps (SSA) as serrated lesions, The investigators excluded hyperplastic lesions in the rectum from the analysis as such lesions are frequently encountered in the rectum
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colon Adenoma
Keywords
FIT- positive, Chromoendoscopy, white light endoscopy, adenoma detection rate, advanced adenoma rate, serrated adenoma rate
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The participants will be randomised to one of the two groups. The first group will undergo colonoscopy evaluation using pan-colonic chromoendoscopy during withdrawal of endoscope. In the second group, colonoscopy evaluation will be performed using high-definition white light endoscopy during withdrawal
Masking
Participant
Allocation
Randomized
Enrollment
250 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Dye based Chromoendoscopy
Arm Type
Active Comparator
Arm Description
The patients enrolled in this group will undergo pan-colonic chromoendoscopy evaluation.
Arm Title
High Definition White Light Endoscopy
Arm Type
Active Comparator
Arm Description
The patients enrolled in this group will undergo high definition white light endoscopy based evaluation
Intervention Type
Diagnostic Test
Intervention Name(s)
Chromoendoscopy
Intervention Description
Participants randomised to Group A will undergo colonoscopic evaluation using dye-based chromoendoscopy
Intervention Type
Diagnostic Test
Intervention Name(s)
High definition white light colonoscopy
Intervention Description
Participants randomised to Group B will undergo colonoscopic evaluation using high definition white light endoscopy
Primary Outcome Measure Information:
Title
To evaluate the adenoma detection rate between pan-colonic chromoendoscopy and white light colonoscopy
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Advanced adenoma detection rate white light colonoscopy
Time Frame
2 years
Title
Flat lesion detection rate
Time Frame
2 years
Title
Serrated adenoma detection rate
Time Frame
2 years
Title
Withdrawal time comparison
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age older than 50 years
Positive stool FIT test or FOBT test
Exclusion Criteria:
Known inflammatory bowel disease
Known polyposis syndromes
Previous history of colon cancer and surgical resection
Overt gastrointestinal bleeding
Stool FIT or FOBT test performed during hospitalization
Inadequate bowel preparation (Boston Bowel Preparation score <6 or <2 for each colonic segment)
Poor patient tolerance to the procedure
Pregnancy
Concurrent intake of anticoagulants and thienopyridines (e.g., Clopidogrel), where these drugs cannot be suspended for the adequate duration before colonoscopy
Patient with known history of hypersensitivity to Indigo carmine dye
Facility Information:
Facility Name
Singapore General Hospital
City
Singapore
ZIP/Postal Code
169608
Country
Singapore
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
21159889
Citation
Pohl J, Schneider A, Vogell H, Mayer G, Kaiser G, Ell C. Pancolonic chromoendoscopy with indigo carmine versus standard colonoscopy for detection of neoplastic lesions: a randomised two-centre trial. Gut. 2011 Apr;60(4):485-90. doi: 10.1136/gut.2010.229534. Epub 2010 Dec 15.
Results Reference
result
PubMed Identifier
28344793
Citation
Cubiella J, Castells A, Andreu M, Bujanda L, Carballo F, Jover R, Lanas A, Morillas JD, Salas D, Quintero E; COLONPREV study investigators. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs. United European Gastroenterol J. 2017 Mar;5(2):255-260. doi: 10.1177/2050640616660662. Epub 2016 Jul 20.
Results Reference
result
Learn more about this trial
Can Pan-Colonic Chromoendoscopy (PCC) Improve Adenoma Detection Rate in FIT-Positive-Patients: A Randomized Study
We'll reach out to this number within 24 hrs